» Articles » PMID: 36679105

In Vitro α-Amylase and α-Glucosidase Inhibitory Activity of Green Seaweed Extract from the Coast of Lhok Bubon, Aceh

Overview
Journal Plants (Basel)
Date 2023 Jan 21
PMID 36679105
Authors
Affiliations
Soon will be listed here.
Abstract

Seaweed belongs to marine biota and contains nutrients and secondary metabolites beneficial for health. This study aimed to determine the antidiabetic activity of extracts and fractions of green seaweed . The sample was extracted with the maceration method using methanol and then partitioned using ethyl acetate and water to obtain ethyl acetate and water fractions. The methanol extract, ethyl acetate fraction, and water fraction of were tested for their inhibitory activity against α-amilase and α-glucosidase. The methanol extract and the fractions with the highest inhibitory activity were phytochemically tested and analyzed using gas chromatography-mass spectrometry (GC-MS). The results showed that the ethyl acetate fraction (IC = 0.88 ± 0.20 mg/mL) inhibited α-amylase relatively similar to acarbose (IC = 0.76 ± 0.04 mg/mL). The methanol extract (IC = 0.05 ± 0.01 mg/mL) and the ethyl acetate fraction (IC = 0.01 ± 0.00 mg/mL) demonstrated stronger inhibitory activity against α-glucosidase than acarbose (IC = 0.27 ± 0.13 mg/mL). Phytochemical testing showed that the methanol extract and the ethyl acetate fraction contained secondary metabolites: alkaloids, flavonoids, steroids, and phenol hydroquinone. The compounds in methanol extract predicted to have inhibitory activity against α-amylase and α-glucosidase were Docosanol, Neophytadiene, Stigmasta-7,22-dien-3-ol,acetate,(3.beta.,5.alpha.,22E), Octadecanoic acid,2-oxo-,methyl ester, and phytol, while those in the ethyl acetate fraction were n-Nonadecane, Phytol, Butyl ester, 14-.Beta.-H-pregna, Octadecenoic acid, and Oleic acid.

Citing Articles

The Ocean's Pharmacy: Health Discoveries in Marine Algae.

Silva M, Avni D, Varela J, Barreira L Molecules. 2024; 29(8).

PMID: 38675719 PMC: 11055030. DOI: 10.3390/molecules29081900.


Seaweeds as Nutraceutical Elements and Drugs for Diabetes Mellitus: Future Perspectives.

Cotas J, Lomartire S, Pereira L, Valado A, Marques J, Goncalves A Mar Drugs. 2024; 22(4).

PMID: 38667785 PMC: 11051413. DOI: 10.3390/md22040168.


Anti-Inflammatory and Immunomodulatory Properties of a Crude Polysaccharide Derived from Green Seaweed : Computational and Experimental Evidences.

Kraiem M, Ben Hamouda S, Eleroui M, Ajala M, Feki A, Dghim A Mar Drugs. 2024; 22(2).

PMID: 38393056 PMC: 10890560. DOI: 10.3390/md22020085.


Identification of dual-target isoxazolidine-isatin hybrids with antidiabetic potential: Design, synthesis, and multiscale molecular modeling approaches.

Ghannay S, Aldhafeeri B, Ahmad I, Albadri A, Patel H, Kadri A Heliyon. 2024; 10(4):e25911.

PMID: 38380049 PMC: 10877290. DOI: 10.1016/j.heliyon.2024.e25911.


HPLC-DAD-MS Characterization, Antioxidant Activity, α-amylase Inhibition, Molecular Docking, and ADMET of Flavonoids from Fenugreek Seeds.

Khenifi M, Serseg T, Migas P, Krauze-Baranowska M, Ozdemir S, Bensouici C Molecules. 2023; 28(23).

PMID: 38067527 PMC: 10708475. DOI: 10.3390/molecules28237798.


References
1.
Xu H . Inhibition kinetics of flavonoids on yeast α-glucosidase merged with docking simulations. Protein Pept Lett. 2010; 17(10):1270-9. DOI: 10.2174/092986610792231492. View

2.
Rocha O, de Felicio R, Rodrigues A, Ambrosio D, Cicarelli R, de Albuquerque S . Chemical profile and biological potential of non-polar fractions from Centroceras clavulatum (C. Agardh) Montagne (Ceramiales, Rhodophyta). Molecules. 2011; 16(8):7105-14. PMC: 6264678. DOI: 10.3390/molecules16087105. View

3.
Su C, Hsu C, Ng L . Inhibitory potential of fatty acids on key enzymes related to type 2 diabetes. Biofactors. 2013; 39(4):415-21. DOI: 10.1002/biof.1082. View

4.
Jhong C, Riyaphan J, Lin S, Chia Y, Weng C . Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico. Biofactors. 2015; 41(4):242-51. DOI: 10.1002/biof.1219. View

5.
Ghani U . Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack. Eur J Med Chem. 2015; 103:133-62. DOI: 10.1016/j.ejmech.2015.08.043. View